BACKGROUND/AIMS: Aldosterone and the mineralocorticoid receptor (MR) play a major role in sodium balance and blood pressure control. They are also involved in adipocyte metabolism. The aim of this study was to analyze the association between the MR p.I180V polymorphism with hypertension and markers of cardiovascular risk. DESIGN AND METHODS: Case-control study nested within a cohort of 2063 subjects followed since birth to date. All subjects (age 23-25 yr old) from the entire cohort with systolic and diastolic hypertension (no.=126) were paired with 398 normotensive controls. MR p.I180V genotype association with anthropometric and biochemical markers of cardiometabolic risk was tested. RESULTS: There was a significant association of the MR p.I180V genotype with body mass index (BMI) and LDL-cholesterol level (p<0.01). Hypertensive subjects carrying the polymorphic G allele (AG or GG genotypes) presented significantly higher BMI (30.0+/-6.0 vs 28.7+/-5.6 kg/m(2); p<0.01) and higher LDL-cholesterol (139.9+/-60.3 vs 109.9+/-35.5 mg/dl; p<0.01). The frequency of the polymorphism MR p.I180V was similar between hypertensive subjects and controls (p=0.15). CONCLUSIONS: The MR p.I180V polymorphism seems to be associated with cardiovascular risk factors including BMI and LDL-cholesterol levels. This original in vivo finding reinforces the role of MR in adipocyte biology and in cardiovascular disease.
BACKGROUND/AIMS: Aldosterone and the mineralocorticoid receptor (MR) play a major role in sodium balance and blood pressure control. They are also involved in adipocyte metabolism. The aim of this study was to analyze the association between the MRp.I180V polymorphism with hypertension and markers of cardiovascular risk. DESIGN AND METHODS: Case-control study nested within a cohort of 2063 subjects followed since birth to date. All subjects (age 23-25 yr old) from the entire cohort with systolic and diastolic hypertension (no.=126) were paired with 398 normotensive controls. MRp.I180V genotype association with anthropometric and biochemical markers of cardiometabolic risk was tested. RESULTS: There was a significant association of the MRp.I180V genotype with body mass index (BMI) and LDL-cholesterol level (p<0.01). Hypertensive subjects carrying the polymorphic G allele (AG or GG genotypes) presented significantly higher BMI (30.0+/-6.0 vs 28.7+/-5.6 kg/m(2); p<0.01) and higher LDL-cholesterol (139.9+/-60.3 vs 109.9+/-35.5 mg/dl; p<0.01). The frequency of the polymorphism MRp.I180V was similar between hypertensive subjects and controls (p=0.15). CONCLUSIONS: The MRp.I180V polymorphism seems to be associated with cardiovascular risk factors including BMI and LDL-cholesterol levels. This original in vivo finding reinforces the role of MR in adipocyte biology and in cardiovascular disease.
Authors: Fabio L Fernandes-Rosa; Margaret de Castro; Ana Claudia Latronico; Wolfgang G Sippell; Felix G Riepe; Sonir R Antonini Journal: J Clin Endocrinol Metab Date: 2006-06-06 Impact factor: 5.958
Authors: Martin D Tobin; Stuart M Raleigh; Stephen Newhouse; Peter Braund; Clare Bodycote; Jenny Ogleby; Deborah Cross; Jay Gracey; Saija Hayes; Terry Smith; Cathy Ridge; Mark Caulfield; Nuala A Sheehan; Patricia B Munroe; Paul R Burton; Nilesh J Samani Journal: Circulation Date: 2005-11-21 Impact factor: 29.690
Authors: Felix G Riepe; Johannes Finkeldei; Luisa de Sanctis; Silvia Einaudi; Alberto Testa; Beate Karges; Michael Peter; Matthias Viemann; Joachim Grötzinger; Wolfgang G Sippell; Geza Fejes-Toth; Nils Krone Journal: J Clin Endocrinol Metab Date: 2006-09-05 Impact factor: 5.958
Authors: D S Geller; A Farhi; N Pinkerton; M Fradley; M Moritz; A Spitzer; G Meinke; F T Tsai; P B Sigler; R P Lifton Journal: Science Date: 2000-07-07 Impact factor: 47.728
Authors: M A Barbieri; H Bettiol; A A M Silva; V C Cardoso; V M F Simões; M R P Gutierrez; J A S Castro; E S O Vianna; M C Foss; J E Dos Santos; R G P Queiroz Journal: Braz J Med Biol Res Date: 2006-08 Impact factor: 2.590
Authors: S R S Freitas; P H Cabello; R S Moura-Neto; L C Dolinsky; A B Lima; M Barros; I Bittencourt; I L Cordovil Journal: Braz J Med Biol Res Date: 2007-03 Impact factor: 2.590
Authors: Alessandra M V Ritter; Ana Paula de Faria; Vanessa Fontana; Rodrigo Modolo; Heitor Moreno Journal: J Clin Hypertens (Greenwich) Date: 2015-08-03 Impact factor: 3.738